Company: PCRX
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001396814-25-000089
Chunk: 0

Company: Pacira BioSciences, Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 10, 2025, Pacira BioSciences, Inc. (the “ Company”) held its 2025 Annual Meeting of Stockholders (the “ Annual Meeting”) in Parsippany, New Jersey and via live webcast online at www. cesonlineservices. com/pcrx25_vm, at which the Company’s stockholders approved the Amended and Restated 2011 Stock Incentive Plan (the “ A& R 2011 Plan”). The A& R 2011 Plan was amended primarily to increase the number of shares of common stock authorized for grant by 2,500,000 newly reserved shares. The A& R 2011 Plan became effective immediately upon stockholder approval at the Annual Meeting.

A summary of the material terms of the A& R 2011 Plan is set forth in the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 29, 2025 (the “ Proxy Statement”). The summaries of the A& R 2011 Plan set forth above and in the Proxy Statement are qualified in their entirety by reference to the full text of the A& R 2011 Plan, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K, and incorporated herein by reference.